Oral mucosal Langerhans' cells as target, effector and rector in HIV infection

被引:34
|
作者
Chou, LL
Epstein, J
Cassol, SA
West, DM
He, W
Firth, JD
机构
[1] Boston Univ, Goldman Sch Dent Med, Oral AIDS Clin, Dept Diagnost Sci, Boston, MA 02118 USA
[2] Univ British Columbia, Fac Dent, Dept Diagnost Sci, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Fac Dent, Dept Oral Biol, Vancouver, BC V5Z 1M9, Canada
[4] Univ Ottawa, Dept Microbiol & Immunol, Ottawa, ON, Canada
关键词
HIV infection; Langerhans' cells; oral hairy leukoplakia;
D O I
10.1034/j.1600-0714.2000.290805.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The mechanism underlying a transition of the oral cavity mucosal epithelium towards susceptibility to opportunistic infections in HIV-seropositive patients was investigated, Phenotypic markers CD1a, HLA-DR, and CD86 of oral mucosal Langerhans' cells (LCs), p17 core protein of human immunodeficiency virus (HIV), and CD45RO of memory T cells were labeled on oral hairy leukoplakia lesional biopsies and clinically normal autologous tissue of HIV-infected patients. HIV p17 protein was detected in association with mucosal LCs, mainly within the lesional epithelium. There were significant correlations between the detection of HIV p17 and the depletion of LCs, and between the depletion of LCs and the presence of hairy leukoplakia lesions. Conjugates of activated LCs and memory T cells were also evident in the submucosal area of lesional biopsies. The findings from this study support the hypothesis that oral mucosal LCs are also the target of HIV infection. Cytopathic changes of LCs caused by productive HIV infection may contribute to selective depletion of LCs, which may impair the mucosal immunologic protection against colonization by microorganisms causing HIV-associated oral mucosal lesions.
引用
收藏
页码:394 / 402
页数:9
相关论文
共 50 条
  • [1] Oral mucosal Langerhans' cells
    Barrett, AW
    Cruchley, AT
    Williams, DM
    CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1996, 7 (01) : 36 - 58
  • [2] LANGERHANS CELLS AS PRIMARY TARGET-CELLS FOR HIV-INFECTION
    BRAATHEN, LR
    RAMIREZ, G
    KUNZE, ROF
    GELDERBLOM, H
    LANCET, 1987, 2 (8567): : 1094 - 1094
  • [3] Infection of oral mucosal cells by HIV-1
    Qureshi, MN
    Barr, CE
    Reidy, J
    PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1996, 5 : 51 - 60
  • [4] LANGERHANS CELLS AND HIV INFECTION
    BRAATHEN, LR
    BIOMEDICINE & PHARMACOTHERAPY, 1988, 42 (05) : 305 - 308
  • [5] Sublingual immunotherapy and oral mucosal Langerhans cells
    Belen Blazquez, Ana
    Mayorga, Cristobalina
    Blanca-Lopez, Natalia
    Torres Jaen, Maria Jose
    IMMUNOTHERAPY, 2011, 3 (01) : 9 - 10
  • [6] LANGERHANS CELLS AND HIV-INFECTION
    ZAMBRUNO, G
    GIANNETTI, A
    BERTAZZONI, U
    GIROLOMONI, G
    IMMUNOLOGY TODAY, 1995, 16 (11): : 520 - 524
  • [7] REDUCED NUMBER OF LANGERHANS CELLS IN ORAL MUCOSAL WASHINGS FROM HIV-1 SEROPOSITIVES
    SPORRI, B
    VONOVERBECK, J
    BRAND, CU
    SCHMIDLI, J
    SANCHEZ, ML
    GRUNOW, R
    BRAATHEN, LR
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (09) : 399 - 402
  • [8] Oral mucosal immunity and HIV/SIV infection
    Lu, F. X.
    Jacobson, R. S.
    JOURNAL OF DENTAL RESEARCH, 2007, 86 (03) : 216 - 226
  • [9] Effects of Candida albicans infection on defense effector secretion by human oral mucosal epithelial cells
    Huang, Fan
    Song, Yuefeng
    Chen, Wei
    Liu, Qin
    Wang, Qiong
    Liu, Weida
    Wang, Xiang
    Wang, Wenmei
    ARCHIVES OF ORAL BIOLOGY, 2019, 103 : 55 - 61
  • [10] LANGERHANS CELLS IN HIV-1 INFECTION
    STINGL, G
    RAPPERSBERGER, K
    TSCHACHLER, E
    GARTNER, S
    GROH, V
    MANN, DL
    WOLFF, K
    POPOVIC, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 22 (06) : 1210 - 1217